PatientLive® opens its doors to the clinical market
Today EvidentIQ announced that its PatientLive® software is opening its doors to the clinical market. The PatientLive®…
Today EvidentIQ announced that its PatientLive® software is opening its doors to the clinical market. The PatientLive®…
XClinical, Teil der EvidentIQ Gruppe begrüßt das Deutsche Krebsforschungszentrum als neuen Kunden. Das Deutsche Krebsf…
Today Carenity, part of the technology-driven data science group EvidentIQ, announced that its PatientLive solution is b…
Die Data-Science-Gruppe EvidentIQ hat über ihr Tochterunternehmen Carenity eine Umfrage mit 3.353 Teilnehmern zur Situat…
Data science group EvidentIQ, with its subsidiary company Carenity, has published a survey with 3,353 participants on th…
In a rapidly growing market, the EvidentIQ offering stands out as it combines a comprehensive tech stack with proven sci…
The newly formed life science group that resulted from the merger of clinical software vendors XClinical and Fortress Me…
Die neu gegründete Life-Science-Gruppe, die aus dem Zusammenschluss der eClinical-Software-Anbieter XClinical und Fortre…
XClinical, an european vendor of innovative software products for e-clinical trials, today announced the invitation to t…
XClinical GmbH, a European vendor of innovative software products for e-clinical trials, successfully passed the ODM cer…